Cosmos Health (NASDAQ:COSM) Posts Earnings Results

Cosmos Health (NASDAQ:COSMGet Free Report) issued its quarterly earnings results on Friday. The company reported ($0.17) earnings per share (EPS) for the quarter, FiscalAI reports. Cosmos Health had a negative net margin of 27.90% and a negative return on equity of 18.32%. The company had revenue of $17.11 million during the quarter.

Cosmos Health Price Performance

COSM stock traded down $0.00 during trading on Friday, reaching $0.72. 202,134 shares of the company were exchanged, compared to its average volume of 466,855. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.82 and a current ratio of 0.98. The stock’s 50 day moving average price is $0.94 and its 200 day moving average price is $0.70. Cosmos Health has a 52-week low of $0.28 and a 52-week high of $1.32. The company has a market cap of $25.22 million, a P/E ratio of -0.70 and a beta of 5.32.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on COSM. Wall Street Zen raised Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Cosmos Health has a consensus rating of “Sell”.

Read Our Latest Research Report on COSM

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Armistice Capital LLC lifted its position in shares of Cosmos Health Inc. (NASDAQ:COSMFree Report) by 156.1% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 1,917,710 shares of the company’s stock after buying an additional 1,168,884 shares during the period. Armistice Capital LLC owned 7.03% of Cosmos Health worth $836,000 as of its most recent SEC filing. Institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

Read More

Earnings History for Cosmos Health (NASDAQ:COSM)

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.